
Medicare and Medicaid Administrator Mehmet Oz speaks during a press briefing in the James S. Brady Press Briefing Room in the White House, in Washington on June 2, 2026. Mandel Ngan/AFP via Getty Images
The U.S. Centers for Medicare and Medicaid Services (CMS) has proposed a permanent framework for its Medicare drug price negotiation program that it said will make the process for lowering costs more transparent.
The agency said in a June 12 statement that the proposed rule also aimed at providing long-term certainty for drugmakers participating in the program.









